Venture Capital News: Breaking Venture Capital News, Comments and Articles. - Page: 4

15:14 EST 28th January 2015 | BioPortfolio

Venture Capital News - Page: 4RSS

Read the latest Venture Capital News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Venture Capital.

Search or Follow Our Venture Capital - Page: 4 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Venture Capital - Page: 4 News.

Showing "venture capital" News Articles 76 to 100 of 8,600+

Tuesday 27th January 2015

InspireMD Receives CE Mark Approval for Its New CGuard RX and Announces Positive Six Month Follow-Up CARENET Trial Data at LINC 2015

BOSTON, Jan. 27, 2015 /PRNewswire/ -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced that it received CE mark approval for its new CGuard RX rapid exchange system for its MicroNet™ covered carotid stent technology.  Concurrently, the Company announced positive 6 month follow up data from its CGuard™ ...

Vivametrica Builds Momentum with Innovation in Health Data Analysis

CALGARY, Alberta, Jan. 27, 2015 /PRNewswire/ -- The global healthcare analytics market is currently estimated at $4.8 billion, with a projected growth to more than $10 billion over the next three years. As this market grows, the need for a standardized method for data collection and management is increasing. Vivametrica today announced that it has reached critical milestones in company growth in 2...

Phonak Audeo V: Experience the power of hearing

STAEFA, Switzerland, Jan. 27, 2015 /PRNewswire/ -- For those requiring a hearing aid, there is no greater feeling than the sense of security that comes with knowing the device is going to deliver seamless sound quality across various listening environments. The latest Phonak product family, Audeo V, employs a new chip technology that offers twice the processing power to provide a quality list...

HealthPrize Technologies Forms New Board of Advisors With Five Thought Leaders From Diverse Fields

NORWALK, Conn., Jan. 27, 2015 /PRNewswire/ -- HealthPrize Technologies, an industry-leading medication adherence and digital patient-engagement company, today announced the formation of a new five-member Board of Advisors. These new advisors will aid the company in thought leadership, product evolution and refinement, and business strategy. "Each advisor brings a wealth of experience and a un...

Nursing Professor Bonnie Franckowiak to Present Research in March on Effect of Self-Efficacy on Treatment Outcomes of Methadone Program Patients

Washington Adventist University nursing professor Bonnie Franckowiak will present her research regarding methadone program patients to the 17th Annual Conference of International Psychiatric-Mental Health Nurses in late March. Takoma Park, Md. (PRWEB) January 27, 2015 Professor Bonnie Franckowiak, who teaches graduate nursing courses in the Washington Adventist University (WAU) School of Graduate...

MagForce AG and MagForce USA, Inc. Announce FDA Pre-IDE Meeting on MagForce's NanoTherm(TM) Prostate Cancer Therapy Pre-Submission

MagForce AG (Frankfurt, Entry Standard, XETRA: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on oncology, together with its subsidiary MagForce USA, Inc. today announced that an in-person meeting was held with the U.S. Food and Drug Administration's (FDA) Center for Devices and Radiological Health to discus...

Schryver acquires Quality Mobile X-Ray Services

Revelstoke Capital Partners portfolio company Schryver Medical Sales and Marketing has completed the acquisition of Quality Mobile X-Ray Services, for an undisclosed sum.

Treato Appoints New Chief Consumer Officer & CMO

PRINCETON, New Jersey, January 27, 2015 /PRNewswire/ -- "The addition of Christine Petersen as Chief Consumer Officer and CMO brings Treato the marketing leadership needed to drive our aggressive growth plan," said Ido Hadari, Treato CEO. "She has the experience and knowledge in the online consumer market as well as marketing and product development expertise to elevate Treato.com as the premier ...

Novartis delivered solid sales growth, margin expansion and pipeline progress in 2014; portfolio transformation will focus company on leading businesses

Novartis International AG / Novartis delivered solid sales growth, margin expansion and pipeline progress in 2014; portfolio transformation will focus company on leading businesses . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement. Net sales grew in FY 2014, with strong core[1] margin expansion Net sales increas...

BRIEF-Quantum Genomics launches 9.1 mln euro capital increase

* Launches 9.1 million euro ($10.2 million) capital increase on Alternext Paris

Monday 26th January 2015

FDA Accepts CTD Holdings' Drug Master File for Second-Generation Orphan Drug

ALACHUA, FL--(Marketwired - January 27, 2015) - CTD Holdings, Inc. (OTCQB: CTDH), a family of biotechnology growth companies that distributes and manufactures cyclodextrin-based products, today announced that the U.S. Food and Drug Administration accepted CTD's Type II Drug Master File No. 28889 covering its second-generation Trappsol® Cyclo™ orphan drug product. The file allows clinicians an...

Miraculins Announces Retail Pharmacy Pilot for Its Scout DS(R) Non-Invasive Diabetes Screening Technology

WINNIPEG, MANITOBA -- (Marketwired) -- 01/27/15 -- Miraculins Inc. (TSX VENTURE: MOM) (the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk assessment technologies for unmet clinical needs, announces that it will be commencing a pilot program with Lovell Drugs Ltd. ("Lovell") and Pear Healthcare Solutions Inc. ("Pear") that w...

Capital City Bank Group, Inc. Reports Fourth Quarter and Full Year 2014 Results

TALLAHASSEE, Fla., Jan. 27, 2015 (GLOBE NEWSWIRE) -- Capital City Bank Group, Inc. (Nasdaq:CCBG) today reported net income of $1.9 million, or $0.11 per diluted share for the fourth quarter of 2014, compared to net income of $2.1 million, or $0.12 per diluted share for the third quarter of 2014, and net income of $2.8 million, or $0.16 per diluted share, for the fourth quarter of 2013. For the fu...

Tribute Pharmaceuticals Provides Update of 2014 Revenues; Anticipates Fourth Quarter Revenue Growth in Excess of 60% and Full Year Revenue Growth of Greater Than 20%

MILTON, ONTARIO -- (Marketwired) -- 01/27/15 -- Tribute Pharmaceuticals Canada Inc. (OTCQX: TBUFF)(TSX VENTURE: TRX) ("Tribute" or the "Company"), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the US, today provided an interim update on its anticipated fourth quarter performance and total fisc...

Cellceutix Enthusiastic About Proposed Budget Increase to $1.2 Billion to Fight Drug-Resistance Bacteria

BEVERLY, MA -- (Marketwired) -- 01/27/15 -- Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology and antimicrobial applications, is pleased to learn this morning that President Barack Obama will call upon Congress to double funding dedicated to fighting drug-resistant bacteria to $1.2 billion in h...

CONMED Corporation Announces Fourth Quarter and Full Year 2014 Financial Results

UTICA, NY -- (Marketwired) -- 01/27/15 -- CONMED Corporation (NASDAQ: CNMD) today announced financial results for the fourth quarter and full year ended December 31, 2014. Fourth Quarter 2014 Financial Highlights: Full Year 2014 Financial Highlights: "Our fourth quarter results allowed us to complete the year in-line with the guidance we provided last July and reconfirmed in October. Our focu...

Orchid Island Capital to Conduct Investor/Analyst Day February 5, 2015

VERO BEACH, Fla., Jan. 27, 2015 (GLOBE NEWSWIRE) -- Orchid Island Capital, Inc. (NYSE:ORC) ("Orchid" or the "Company"), a real estate investment trust ("REIT"), today announced that it will conduct an investor and analyst day at its offices in Vero Beach, Florida next Thursday, February 5, 2015. In addition, management presentations will be simultaneously webcast and will be available for replay ...

Cleveland BioLabs Announces Results of Special Meeting of Stockholders and Reverse Stock Split

BUFFALO, NY -- (Marketwired) -- 01/27/15 -- Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that at a special meeting of stockholders held on January 27, 2015, stockholders authorized the Company's Board of Directors to effect a reverse stock split of the Company's common stock at a ratio in the range of 1:2 to 1:20. The Board of Directors thereafter approved the filing of a Certificate o...

Schryver Medical completes acquisition of Quality Mobile X-Ray Services Inc.

Schryver Medical Sales and Marketing, LLC (Denver), a portfolio company of Revelstoke Capital Partners, a Denver-based private equity firm, has completed the acquisition of Quality Mobile X-Ray Services, Inc. http://www.businesswire.com/news/home/...

First NUsurface® Meniscus Implant implanted in the US for early Knee Osteoarthritis

Active Implants LLC today announced the first implantation in the United States of the NUsurface® Meniscus Implant, designed to treat patients with persistent knee pain due to an injured or deteriorated meniscus. The procedure was performed by Christopher Kaeding, M.D., Professor and Executive Director, of OSU Sports Medicine at The Ohio State University ...

EPIRUS Announces Proposed Public Offering of Common Stock

EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS), a Boston-based biopharmaceutical company focused on the global development of biosimilar monoclonal antibodies, announced today that it has commenced an underwritten public offering of shares of its common stock. EPIRUS intends to grant the underwriters a 30-day option to purchase up to an additional 15...

Americans Faced Double Digit Increases in Prescription Drug Prices in 2014, According to Truveris National Drug IndexSM

Branded Drugs Jump 15%, Specialty Drugs Rise 10%, Generics Up 5% Americans faced double-digit price increases for prescription medications in 2014, with brand, generic and specialty drugs combined rising 10.9%, according to the Truveris National Drug Index, which today reported its full year figures for the first time.

Cure Duchenne Launches “Cure Duchenne Cares”, a Physical Therapy, Education and Outreach Program for the Duchenne Community

CureDuchenne, a nonprofit that raises awareness and funds research to find a cure for Duchenne muscular dystrophy, today launched CureDuchenne Cares, a physical therapy, education and outreach program for the Duchenne community. CureDuchenne has partnered with the

Meet, Hear and Speak with Investors, Strategists and Industry-Leading Companies at our Chicago Conference

MedCity Media and MHIN (Mid-America Healthcare Investors Network) are bringing back The MidAmerica Healthcare Venture Forum to Chicago, March 10-11 – just a few weeks away! Reserve your ticket before early bird registration ends on January...

Wolf Administration Urges Pennsylvanians to Stay Safe in Inclement Weather

HARRISBURG, Pa., Jan. 26, 2015 /PRNewswire-USNewswire/ -- As cold temperatures and snow blanket the commonwealth, the departments of Human Services and Health are urging Pennsylvanians to take commonsense steps to reduce the risk of health hazards during and after the storm. "It's critically important that Pennsylvanians use extreme caution to protect their health and safety with the impending st...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks